(Q36342545)

English

Breast cancer biomarkers.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

Breast cancer biomarkers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

Gabriel N Hortobagyi

4

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Jeffrey S Ross

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

W Fraser Symmans

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Lajos Pusztai

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Advances in Clinical Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

40

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

99-125

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer biomarkers and molecular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroid hormone receptors in breast cancer management

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal therapy of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling of primary breast carcinomas using arrays of candidate genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential Clinical Utility of Serum HER-2/neu Oncoprotein Concentrations in Patients with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic markers as prognostic indicators in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclins and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclin E and survival in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

p27 expression correlates with short-term, but not with long-term prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of cell-cycle regulator p27 is correlated to the prognosis and ER expression in breast carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of mutations in TP53 and RAS genes in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological and clinical associations of c-jun activation in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

TP53 and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Spectrum of p53 tumor suppressor gene mutations and breast cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

P53 gene mutations: case study of a clinical marker for solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The p53 pathway in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of proliferating cell nuclear antigen, Ki-67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytologic samples of breast cancer: an immunochemical study with clinical, pathobiological, and histologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adhesion molecules in cancer biology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

E-cadherin as a prognostic indicator in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent E-cadherin expression in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CD44v6 is not a prognostic factor in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Laminin receptors, collagenase IV and prognosis in node-negative breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of apoptosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Number of apoptotic cells as a prognostic marker in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of apoptosis regulators in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A prognostic index for operable, node-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical expression of caspase-3 as an adverse indicator of the clinical outcome in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cathepsin D and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinases: a tail of a frog that became a prince

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinases: multifunctional contributors to tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Roles of the matrix metalloproteinases in mammary gland development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiogenesis in human cancer: implications in cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Individualized care for patients with cancer - a work in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on pharmacogenetics in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Using mRNA expression profiling to determine anticancer drug efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The detection of circulating breast cancer cells in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA methylation and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2805%2940003-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0065-2423(05)40003-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16355921%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36342545&oldid=1606502151"